Sudeep Pharma Limited (NSE: SUDEEPPHRM) stock price moves up 5% intraday to ₹874.6, breaking out from its 6M resistance trendline in the Healthcare sector.
Glenmark Pharmaceuticals Limited launches Methylene Blue Injection USP in USA, expanding access to affordable healthcare solutions.
Zydus Lifesciences Limited (ZYDUSLIFE) completes acquisition of Assertio Holdings, acquiring 66.32% of shares at $23.50 per share.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 10% intraday. The stock cleared its 6M resistance trendline, marking a strong upward move in th.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock clears its 6M resistance trendline, gaining 10% intraday. This breakout signals a strong upward trend in the health.
Metropolis Healthcare Limited (NSE: METROPOLIS) gains 5% intraday to ₹554.5, showing a recovery despite an underlying trendline breakdown..
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 9% intraday. The stock cleared its 6M resistance trendline, signaling a strong upward move in t.
Dr. Lal Path Labs Ltd. (LALPATHLAB) stock breaks out, gaining 8% intraday, clearing its 6M resistance trendline in the healthcare diagnostics sector.
Suven Life Sciences Limited (NSE: SUVEN) successfully completes Phase-1 study for SUVN-I6107, advancing to Phase-2.